!_Professional_! schreef op 12 maart 2019 15:28:
Deze UNAUDITED numbers zijn bekend -->
www.pharming.com/sites/default/files/... page 18/20
'consolidated statement of cashflows'
working cap verslechetering 4.4m en ze beginnen met operating result...
maar als je goed kijkt is operating result (EUR 37.9m) nietszeggend --> page 13/20
www.pharming.com/sites/default/files/... immers het wordt vrijwel geheel teniet gedaan door 'Other financial income and expenses'van EUR 36.6m
simpele manier is net income 24.9m - dta 25.9 = negative underlying result
[In addition, the increasing profitability of Pharming means that we are likely to be able to use all of our accumulated net operating tax losses, and so we have increased the deferred tax asset which recognises these by a net amount of €25.6 million (2017: €9.4 million), being mainly the tax effect of the total
accumulated losses to date in the Netherlands. ]